Showing 1481-1490 of 10596 results for "".
Lengthening Telomeres?
https://reachmd.com/programs/what-your-patients-are-talking-about/lengthening-telomeres/7168/Dr. McDonough discusses an interesting report in The Lancet Oncology regarding telomeres.Future Cardiovascular Disease & the Big Impact of Small Salt Reductions
https://reachmd.com/programs/heart-matters/future-cardiovascular-disease-the-big-impact-of-small-salt-reductions/5257/We are well aware that the overabundance of processed, frozen and fast foods contribute to many Americans exceeding the recommended daily allowance of sodium. But there are potentially enormous cardiovascular benefits to cutting down on salt intake by even a very modest amount. How can we quantify tPilots as Patients: You're the Flight Surgeon
https://reachmd.com/programs/clinicians-roundtable/pilots-as-patients-youre-the-flight-surgeon/3169/As a specialist in aerospace physiology and altitude-related clinical conditions, Dr. Jan Stepanek, medical director of the Aerospace Medical Program, assistant professor of medicine at the Mayo Clinic in Scottsdale, AZ, and aviation medical examiner (AME) discusses medical qualifications for pilotsSurgical Crossroads: Practical Considerations for Optimizing Treatment in TGCT
https://reachmd.com/programs/cme/surgical-crossroads-practical-considerations-for-optimizing-treatment-in-tgct/48907/Explore TGCT recognition, clinical evidence, treatment strategies, and management of adverse events with CSF1R inhibitors in an interdisciplinary context.The Future of Food Allergy Treatment: Immunotherapy and Biologic Advances
https://reachmd.com/programs/frontlines-food-allergies/the-future-of-food-allergy-treatment-immunotherapy-and-biologic-advances/26314/Join us as we explore two recent advancements in food allergy treatment and the common side effects associated with each approach.Beyond the Scalpel: When TGCT Surgery Isn’t the Solution
https://reachmd.com/programs/cme/beyond-the-scalpel-when-tgct-surgery-isnt-the-solution/48904/Explore TGCT recognition, clinical evidence, treatment strategies, and management of adverse events with CSF1R inhibitors in an interdisciplinary context.Evaluating Alemtuzumab in Adult ALL: Insights from a Phase 1/2 Clinical Trial
https://reachmd.com/programs/project-oncology/evaluating-alemtuzumab-in-adult-all-insights-from-a-phase-12-clinical-trial/32993/Alemtuzumab may have potential as an adult acute lymphoblastic leukemia treatment. Dive deeper into its safety, efficacy, and implications for care.Leveraging Wearables for Pulmonary Arterial Hypertension Care
https://reachmd.com/programs/clinicians-roundtable/leveraging-wearables-for-pulmonary-arterial-hypertension-care/56329/Wearable devices and sensors are transforming how clinicians monitor and assess patients with pulmonary arterial hypertension between visits. Join Dr. Daniel Lachant as he explores how real-world activity data and heart rate metrics can enhance risk assessment, guide treatment decisions, and improveLooking to the Future of Gastroenterology: Where Are We Headed?
https://reachmd.com/programs/gi-insights/looking-to-the-future-of-gastroenterology-where-are-we-headed/13851/What might the practice of gastroenterology look like 10 years from now? Join us as we work to clear up that crystal ball.Leading Disaster Medicine Initiatives in the US and Beyond
https://reachmd.com/programs/the-pulse-of-emergency-medicine/Leading-Disaster-Medicine-initiatives-in-the-US-and-beyond/8016/Dr. Andrew Bern reflects on the evolution of the Disaster Medicine subspecialty and describes his continuing work in Ecuador.